Investigación > Neurociencias

Grupo de Estudio de la Cognición y la Conducta

Número de publicaciones
91
Buscador de publicaciones

  • García-González P; de Rojas I; Moreno-Grau S; Montrreal L; Puerta R; Alarcón-Martín E; Quintela I; Orellana A; Andrade V; Adami PVM; Heilmann-Heimbach S; Gomez-Garre P; Periñán MT; Alvarez I; Diez-Fairen M; Nuñez Llaves R; Olivé Roig C; Garcia-Ribas G; Menéndez-González M; Martínez C; Aguilar M; Buongiorno M; Franco-Macías E; Saez ME; Cano A; Bullido MJ; Real LM; Rodríguez-Rodríguez E; Royo JL; Álvarez V; Pastor P; Piñol-Ripoll G; Mir P; Lara MC; Padilla MM; Sánchez-Juan P; Carracedo A; Valero S; Hernandez I; Tàrraga L; Ramirez A; Boada M; Ruiz A

    Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. .

    [doi:10.3390/ijms24020898]

  • Dakterzada F; Jové M; Cantero JL; Pamplona R; Piñoll-Ripoll G

    Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease.

    Redox Biology 64 102772-102772. .

    [doi:10.1016/j.redox.2023.102772]

  • González-Mingot, C; Gil-Sánchez, A; Canudes-Solans, M; Peralta-Moncusi, S; Solana-Moga, MJ; Brieva-Ruiz, L

    Preventive treatment can reverse cognitive impairment in chronic migraine

    JOURNAL OF HEADACHE AND PAIN 23 -. .

    [doi:10.1186/s10194-022-01486-w]

  • Dakterzada, Farida; Benitez, Ivan D.; Targa, Adriano; Carnes, Anna; Pujol, Montse; Jove, Mariona; Minguez, Olga; Vaca, Rafi; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; Pamplona, Reinald; Piñol-Ripoll G

    Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer's disease.

    Alzheimers Research & Therapy 14 163-163. .

    [doi:10.1186/s13195-022-01102-8]

  • Chino-Vilca B; Rodríguez-Rojo IC; Torres-Simón L; Cuesta P; Vendrell AC; Piñol-Ripoll G; Huerto R; Tahan N; Maestú F

    Sex specific EEG signatures associated with cerebrospinal fluid biomarkers in mild cognitive impairment.

    CLINICAL NEUROPHYSIOLOGY 142 190-198. .

    [doi:10.1016/j.clinph.2022.08.007]

  • Vazquez-Justes, D; Aguirregoicoa, I; Fernandez, L; Carnes-Vendrell, A; Dakterzada, F; Sanjuan, L; Mena, A; Piñol-Ripoll G

    Clinical impact of microbleeds in patients with Alzheimer's disease.

    BMC Geriatrics 22 774-774. .

    [doi:10.1186/s12877-022-03456-y]

  • Villarejo-Galende A; García-Arcelay E; Piñol-Ripoll G; Del Olmo-Rodríguez A; Viñuela F; Boada M; Franco-Macías E; de la Peña AI; Riverol M; Puig-Pijoan A; Abizanda-Soler P; Arroyo R; Baquero-Toledo M; Feria-Vilar I; Balasa M; Berbel Á; Rodríguez-Rodríguez E; Vieira-Campos A; García-Ribas G; Rodrigo-Herrero S; Lleó A; Maurino J

    Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain.

    Neurology and Therapy 11 1183-1192. .

    [doi:10.1007/s40120-022-00367-3]

  • Boada, M; Lopez, OL; Olazaran, J; Nunez, L; Pfeffer, M; Puente, O; Pinol-Ripoll, G; Gamez, JE; Anaya, F; Kiprov, D; Alegret, M; Grifols, C; Barcelo, M; Bozzo, J; Szczepiorkowski, ZM; Paez, A; AMBAR Trial Grp

    Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

    ALZHEIMERS & DEMENTIA 18 1314-1324. .

    [doi:10.1002/alz.12477]

  • Le Guen Y; Belloy ME; Grenier-Boley B; de Rojas I; Castillo-Morales A; Jansen I; Nicolas A; Bellenguez C; Dalmasso C; Küçükali F; Eger SJ; Rasmussen KL; Thomassen JQ; Deleuze JF; He Z; Napolioni V; Amouyel P; Jessen F; Kehoe PG; van Duijn C; Tsolaki M; Sánchez-Juan P; Sleegers K; Ingelsson M; Rossi G; Hiltunen M; Sims R; van der Flier WM; Ramirez A; Andreassen OA; Frikke-Schmidt R; Williams J; Ruiz A; Lambert JC; Greicius MD; Arosio B; Benussi L; Boland A; Borroni B; Caffarra P; Daian D; Daniele A; Debette S; Dufouil C; Düzel E; Galimberti D; Giedraitis V; Grimmer T; Graff C; Grünblatt E; Hanon O; Hausner L; Heilmann-Heimbach S; Holstege H; Hort J; Jürgen D; Kuulasmaa T; van der Lugt A; Masullo C; Mecocci P; Mehrabian S; de Mendonça A; Moebus S; Nacmias B; Nicolas G; Olaso R; Papenberg G; Parnetti L; Pasquier F; Peters O; Pijnenburg YAL; Popp J; Rainero I; Ramakers I; Riedel-Heller S; Scarmeas N; Scheltens P; Scherbaum N; Schneider A; Seripa D; Soininen H; Solfrizzi V; Spalletta G; Squassina A; van Swieten J; Tegos TJ; Tremolizzo L; Verhey F; Vyhnalek M; Wiltfang J; Boada M; García-González P; Puerta R; Real LM; Álvarez V; Bullido MJ; Clarimon J; García-Alberca JM; Mir P; Moreno F; Pastor P; Piñol-Ripoll G; Molina-Porcel L; Pérez-Tur J; Rodríguez-Rodríguez E; Royo JL; Sánchez-Valle R; Dichgans M; Rujescu D

    Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.

    JAMA Neurology 79 652-663. .

    [doi:10.1001/jamaneurol.2022.1166]

  • Galende, AV; Garcia-Arcelay, E; Pinol-Ripoll, G; Del Olmo-Rodriguez, A; Vinuela, F; Rovira, MB; Franco-Macias, E; Ibanez, A; Riverol, M; Pijoan, AP; Abizanda, P; Gonzalez, RA; Baquero, M; Feria, L; Balasa, M; Berbel, A; Rodriguez-Rodriguez, E; Vieira, A; Garcia-Ribas, G; Rodrigo-Herrero, S; Lleo, A; Morales, EA; Catalan-Flores, C; Maurino, J

    Person-centered Assessment in Early Alzheimers Disease (P1-1.Virtual)

    Neurology 98 -. .

  • Torres-Bondia F; de Batlle J; Galván L; Buti M; Barbé F; Piñol-Ripoll G

    Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015.

    BMC PUBLIC HEALTH 22 818-818. .

    [doi:10.1186/s12889-022-13217-6]

  • Torres-Bondia F; Dakterzada F; Galván L; Buti M; Besanson G; Grill E; Buil R; de Batlle J; Piñol-Ripoll G

    Benzodiazepine and Z-drug use and the risk of developing dementia.

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 25 261-268. .

    [doi:10.1093/ijnp/pyab073]